TG Therapeutics Inc (TGTX)
34.50
+3.36
(+10.77%)
USD |
NASDAQ |
Nov 21, 16:00
34.60
+0.10
(+0.28%)
After-Hours: 20:00
TG Therapeutics Revenue (Quarterly): 83.88M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 83.88M |
| June 30, 2024 | 73.47M |
| March 31, 2024 | 63.47M |
| December 31, 2023 | 43.97M |
| September 30, 2023 | 165.82M |
| June 30, 2023 | 16.07M |
| March 31, 2023 | 7.803M |
| December 31, 2022 | 0.08M |
| September 30, 2022 | 0.094M |
| June 30, 2022 | 0.594M |
| March 31, 2022 | 2.016M |
| December 31, 2021 | 2.321M |
| September 30, 2021 | 2.03M |
| June 30, 2021 | 1.545M |
| March 31, 2021 | 0.793M |
| December 31, 2020 | 0.038M |
| September 30, 2020 | 0.038M |
| June 30, 2020 | 0.038M |
| March 31, 2020 | 0.038M |
| December 31, 2019 | 0.038M |
| September 30, 2019 | 0.038M |
| June 30, 2019 | 0.038M |
| March 31, 2019 | 0.038M |
| December 31, 2018 | 0.038M |
| September 30, 2018 | 0.038M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.038M |
| March 31, 2018 | 0.038M |
| December 31, 2017 | 0.038M |
| September 30, 2017 | 0.038M |
| June 30, 2017 | 0.038M |
| March 31, 2017 | 0.038M |
| December 31, 2016 | 0.0377M |
| September 30, 2016 | 0.0381M |
| June 30, 2016 | 0.0381M |
| March 31, 2016 | 0.0381M |
| December 31, 2015 | 0.0381M |
| September 30, 2015 | 0.0381M |
| June 30, 2015 | 0.0381M |
| March 31, 2015 | 0.0381M |
| December 31, 2014 | 0.0381M |
| September 30, 2014 | 0.0381M |
| June 30, 2014 | 0.0381M |
| March 31, 2014 | 0.0381M |
| December 31, 2013 | 0.0381M |
| September 30, 2013 | 0.0381M |
| June 30, 2013 | 0.0381M |
| March 31, 2013 | 0.0381M |
| December 31, 2012 | 0.019M |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.038M
Minimum
Dec 2019
165.82M
Maximum
Sep 2023
23.21M
Average
1.780M
Median
Revenue (Quarterly) Benchmarks
| ADMA Biologics Inc | 119.84M |
| Varex Imaging Corp | 205.70M |
| Rhythm Pharmaceuticals Inc | 33.25M |
| Inspire Medical Systems Inc | 203.19M |
| Mirum Pharmaceuticals Inc | 90.38M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.88M |
| Total Expenses (Quarterly) | 71.44M |
| EPS Diluted (Quarterly) | 0.02 |
| Enterprise Value | 4.752B |
| Gross Profit Margin (Quarterly) | 88.86% |
| Profit Margin (Quarterly) | 4.63% |
| Earnings Yield | -0.32% |
| Normalized Earnings Yield | -0.3188 |